To further evaluate the independent predictive ability of CD8 + CD4FOXP3 in predicting GC patients’ survival, we combined the CD8 + CD4FOXP3 with other GC clinicopathologic factors as categorical variables in a Cox proportional hazards model. This evidence concerns the gene CD8A and gastric cancer.